ConvaTec Announces 2012 Second Quarter Earnings Call

Analyst and Investor Call To Be Held On August 29, 2012

SKILLMAN, N.J., Aug. 24, 2012 /PRNewswire/ -- ConvaTec today announced that it will report its 2012 second quarter earnings on Wednesday, August 29, 2012. Ken Berger, CEO and Ed Borkowski, CFO will host an analyst and investor call at 9:00 AM ET live via telephone.

To participate in the conference call within the U.S. and Canada, dial (866) 524-0629.

To participate in the conference internationally, dial (708) 290-1340.

The conference ID is 23133321

Participants should dial in 10 minutes prior to the start of the call. The Company's unaudited, 2012 Second Quarter Report will be filed on the Company's website prior to the call under the Investor Community tab at www.convateccorporate.com.

For more information, please contact [email protected]

About ConvaTec
ConvaTec is a leading developer and marketer of innovative medical technologies that have helped improve the lives of millions of people worldwide. With four key focus areas – Ostomy Care, Wound Therapeutics, Continence and Critical Care, and Infusion Devices – ConvaTec products support healthcare professionals from the hospital to the community health setting. For more information, please visit www.convatec.com.

Investor Relations:

Media Relations:

Tim Winston

Amy Firsching

VP, Treasurer

Associate Director, Corporate Communications

ConvaTec

ConvaTec

908-904-2088

908-904-2988

[email protected]

[email protected]

SOURCE ConvaTec

Suggested Articles

J&J's talc woes deepened Friday after the FDA turned up "sub-trace" levels of asbestos one bottle of the company's baby powder,…

Another major drugmaker is recalling in the U.K. 10 batches of its Zantac generics because they contain a possible carcinogen.

With diagnosis rates on the rise, Pfizer's Vyndaqel franchise could collect $157 million in 2019 U.S. sales, well above consensus, SVB Leerink says.